Seminars in Liver Disease

Papers
(The TQCC of Seminars in Liver Disease is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
The NLRP3 Inflammasome in Alcoholic and Nonalcoholic Steatohepatitis65
Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity55
Noninvasive Diagnostics for Portal Hypertension: A Comprehensive Review45
Effects of Mediterranean Diet in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Randomized Controlled Trials37
Alagille Syndrome: A Focused Review on Clinical Features, Genetics, and Treatment31
Role of FXR in Bile Acid and Metabolic Homeostasis in NASH: Pathogenetic Concepts and Therapeutic Opportunities29
Direct or Collateral Liver Damage in SARS-CoV-2–Infected Patients28
Management of Acute Liver Failure: Update 202228
Interleukin-17 in Liver Disease Pathogenesis27
Hepatic Alveolar Echinococcosis27
Cellular Senescence in Liver Disease and Regeneration26
Aging and Chronic Liver Disease24
The Role of Liver Zonation in Physiology, Regeneration, and Disease21
Simplification of Care for Chronic Hepatitis C Virus Infection20
Machine Perfusion: Cold versus Warm, versus Neither. Update on Clinical Trials19
Molecular Mechanisms of Hepatoblastoma19
Nonalcoholic Steatohepatitis Drug Development Pipeline: An Update18
Early Diagnosis and Prevention of Infections in Cirrhosis17
Nonalcoholic Fatty Liver Disease: Current Global Burden16
Adjuvant versus Neoadjuvant Immunotherapy for Hepatocellular Carcinoma: Clinical and Immunologic Perspectives15
Plasma Exchange in Acute and Acute on Chronic Liver Failure15
Evolution of Liver Transplant Selection Criteria and U.S. Allocation Policy for Patients with Hepatocellular Carcinoma15
Finite Antiviral Therapy in Chronic Hepatitis B Patients with Cirrhosis15
Role of Multidisciplinary Care in the Management of Hepatocellular Carcinoma14
Hepatitis C Virus Treatment in Children: A Challenge for Hepatitis C Virus Elimination14
A Global Systematic Review of Hepatitis C Elimination Efforts through Micro-Elimination14
Noninvasive Tests in the Assessment of NASH and NAFLD Fibrosis: Now and Into the Future13
Differential Roles for Diploid and Polyploid Hepatocytes in Acute and Chronic Liver Injury13
Deciphering Tumor Heterogeneity in Hepatocellular Carcinoma (HCC)—Multi-Omic and Singulomic Approaches13
The Inside-Out of End-Stage Liver Disease: Hepatocytes are the Keystone13
New Developments in Microbiome in Alcohol-Associated and Nonalcoholic Fatty Liver Disease12
Wearables, Physical Activity, and Exercise Testing in Liver Disease12
Management of Obesity and Nonalcoholic Fatty Liver Disease: A Literature Review12
The Current Status of Granulocyte-Colony Stimulating Factor to Treat Acute-on-Chronic Liver Failure12
Intrahepatic Cholestasis of Pregnancy: Natural History and Current Management12
Scavenger Receptors: Novel Roles in the Pathogenesis of Liver Inflammation and Cancer11
Shared Mechanisms between Cardiovascular Disease and NAFLD11
Combination Immunotherapy for Hepatocellular Carcinoma: Where Are We Currently?10
Gut–Liver Axis in Nonalcoholic Fatty Liver Disease: the Impact of the Metagenome, End Products, and the Epithelial and Vascular Barriers10
Risks and Rewards of Bariatric Surgery in Advanced Chronic Liver Diseases10
Clinical Application and Progress of Fecal Microbiota Transplantation in Liver Diseases: A Review9
NAFLD in Cardiovascular Diseases: A Contributor or Comorbidity?9
Mechanisms of Pharmacoresistance in Hepatocellular Carcinoma: New Drugs but Old Problems9
Treating Alcohol Use Disorder in Patients with Alcohol-Associated Liver Disease: Controversies in Pharmacological Therapy9
Nonalcoholic Steatohepatitis Promoting Kinases9
Metabolic Injury of Hepatocytes Promotes Progression of NAFLD and AALD9
Drug-Induced Vanishing Bile Duct Syndrome: From Pathogenesis to Diagnosis and Therapeutics9
0.018410921096802